Levamisole

Zoetis Announces First Quarter 2024 Results

Retrieved on: 
Thursday, May 2, 2024
Health, Other Health, Fitness & Nutrition, General Health, Pharmaceutical, Veterinary, Poultry, OA, Summit, Coccidioides immitis, International, Investment, Weather, Fear, Weight gain, Cattle, Levamisole, Animal, Panic, Horse, Growth, Webcast, Transport, Vaccine, Sarolaner, Metritis, Tick, Cat, MFA, Parasitism, Food, Human, Acquisition, Livestock, Mycoplasma bovis, Inc., Dog, EZ, Sheep, Dermatology, RTU

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.
  • The company reported revenue of $2.2 billion for the first quarter of 2024, an increase of 10% compared with the first quarter of 2023.
  • On an operational1 basis, revenue for the first quarter of 2024 increased 12% compared with the first quarter of 2023.
  • Zoetis will host a webcast and conference call at 8:30 a.m. (ET) today, during which company executives will review first quarter 2024 results, discuss financial guidance and respond to questions from financial analysts.

Farm Animal Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026) - ResearchAndMarkets.com

Retrieved on: 
Monday, February 21, 2022
Agriculture, Natural Resources, Levamisole, Animal and Plant Health Inspection Service, Health, Nematomorpha, US FDA, Salmonella enterica subsp. enterica, Coronavirus, Animal, European Medicines Agency, COVID-19, Ceva, United Kingdom, Center, Current Opinion (Elsevier), Parasitism, Coccidia, Livestock, US, Fenbendazole, Acquisition, Veterinary biologic, Food, Vaccine, Severe acute respiratory syndrome coronavirus 2, CVB, Reproduction, Degenerative disease, Welfare, Food and Agriculture Organization, Technology, Merck, Agriculture, Vaccination, Current Opinion, Eprinomectin, APHIS, Boehringer Ingelheim, Growth, Virology, Albendazole

The "Farm Animal Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Farm Animal Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • Hence, a slight short-term negative impact is witnessed on the farm animal healthcare market, during the outbreak of COVID-19.
  • Parasiticides Represents High Growth Opportunities for Farm Animal Healthcare, Over the Forecast Period
    Parasiticides are in high demand, for treating many diseases in farm animals.
  • It currently holds the major share of the farm animal healthcare market, and it is expected to follow the same trend over the forecast period.

Worldwide Farm Animal Healthcare Industry to 2026 - North America Dominates the Market - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 1, 2021
Agriculture, Natural Resources, Parasitism, Animal, Animal and Plant Health Inspection Service, Salmonella enterica subsp. enterica, Eprinomectin, Veterinary biologic, Health, Degenerative disease, APHIS, Livestock, Levamisole, Agriculture, Coccidia, Vaccine, Vaccination, Boehringer Ingelheim, Center, Reproduction, Ceva, US, Fenbendazole, United Kingdom, US FDA, CVB, Growth

Parasiticides Represents High Growth Opportunities for Farm Animal Healthcare, Over the Forecast Period

Key Points: 
  • Parasiticides Represents High Growth Opportunities for Farm Animal Healthcare, Over the Forecast Period
    Parasiticides are in high demand, for treating many diseases in farm animals.
  • With the growth of the animal husbandry industry, an excess increase in demand in veterinary pharmaceuticals is expected.
  • North America region is among the major contributor to agriculture, livestock, technological advancements and implementation of farm animal healthcare benefits across the region.
  • It currently holds the major share of the farm animal healthcare market, and it is expected to follow the same trend over the forecast period.